Author
Number of items: 122.
2018
Combined NMDA Inhibitor Use in a Patient With Multisubstance-induced Psychotic Disorder. (2018)
Matteo Caloro,
Giuseppa Calabrò,
Eleonora de Pisa,
Enrico Rosini,
Georgios D Kotzalidis,
Davide Lonati,
Carlo Alessandro Locatelli,
Pietro Papa,
Fabrizio Schifano
and
Paolo Girardi
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review. (2018)
Fabrizio Schifano,
Stefania Chiappini,
John Corkery
and
Amira Guirguis
Exploration of the use of new psychoactive substances by individuals in treatment for substance misuse in the UK. (2018)
Rosalind Gittins,
Amira Guirguis,
Fabrizio Schifano
and
Ian Maidment
Is there a potential of misuse for venlafaxine and bupropion? (2018)
Fabrizio Schifano
and
Stephania Chiappini
Is There a Potential of Misuse for Quetiapine? (2018)
Stefania Chiappini
and
Fabrizio Schifano
2017
Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances : A Comeback to the Shamanism? (2017)
Laura Orsolini,
Paul St John-Smith,
Daniel McQueen,
Duccio Papanti,
John Corkery
and
Fabrizio Schifano
The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review. (2017)
Laura Orsolini,
Duccio Papanti,
Domenico De Berardis,
Amira Guirguis,
John Corkery
and
Fabrizio Schifano
An exploratory study of information sources and key findings on UK cocaine-related deaths. (2017)
John Corkery,
Hugh Claridge,
Christine Goodair
and
Fabrizio Schifano
Technologies and Lifestyles : how the Internet has revolutionized the drug market and people’s lives. (2017)
Ornella Corazza,
Francesco Saverio Bersani,
Giuseppe Valeriani
and
Fabrizio Schifano
4,4’-dimethylaminorex (‘4,4’-DMAR’; ‘Serotoni’) misuse; a web-based study. (2017)
Barbara Loi,
Mire Zloh,
Maria Antonietta,
John Corkery
and
Fabrizio Schifano
Can mobile phone technology support a rapid sharing of information on Novel Psychoactive Substances among health and other professionals internationally? (2017)
Pierluigi Simonato,
Francesco Saverio Bersani,
Rita Santacroce,
Eduardo Cinosi,
Fabrizio Schifano,
Giuseppe Bersani,
Giovanni Martinotti
and
Ornella Corazza
From concept(ion) to life after death/the grave: the ‘natural’ history and life-cycle(s) of Novel Psychoactive Substances (NPS). (2017)
Laura Orsolini,
John Corkery,
Duccio Papanti
and
Fabrizio Schifano
Intended and Unintended Use of Cathinone Mixtures. (2017)
Amira Guirguis,
John Corkery,
Jacqueline Stair,
Stewart Kirton,
Mire Zloh
and
Fabrizio Schifano
An insight into the deep web; why it matters for addiction psychiatry? (2017)
Laura Orsolini,
Duccio Papanti,
John Corkery
and
Fabrizio Schifano
A matter of life and death : substance-caused and substance-related fatalities in Ibiza in 2015. (2017)
Rita Santacroce,
Claudia Ruiz Bennasar,
Juan Ramon Sancho Jaraiz,
Federica Fiori,
Fabiola Sarchione,
Federica Angelini,
Gabriella Catalano,
Maria Luisa Carenti,
John Martin Corkery,
Fabrizio Schifano,
Massimo di Giannantonio
and
Giovanni Martinotti
Cannabis; epidemiological, neurobiological and psychopathological issues: an update. (2017)
Maria Antonietta De Luca,
Gaetano Di Chiara,
Cristina Cadoni,
Daniele Lecca,
Laura Orsolini,
Duccio Papanti,
John Corkery
and
Fabrizio Schifano
2016
Use of benzylglycinamide by a HIV-seropositive polysubstance user: : the changing pattern of novel psychoactive substance use among youths. (2016)
Matteo Caloro,
Giuseppa Calabro,
Georgios D. Kotzalidis,
Ilaria Cuomo,
John Martin Corkery,
Alessandro Emilio Vento,
Luana Lionetto,
Sergio De Filippis,
Valentina Ranieri,
Davide Lonati,
Carlo Alessandro Locatelli,
Eleonora de Pisa,
Antonio Di Tommaso,
Paolo Girardi
and
Fabrizio Schifano
Substance use and misuse - Legal highs. (2016)
Amira Guirguis,
Rosalind Gittins,
John Corkery
and
Fabrizio Schifano
Novel Psychoactive Substances: : the pharmacology of stimulants and hallucinogens. (2016)
Fabrizio Schifano,
Duccio Papanti,
Laura Orsolini
and
John Corkery
A Decade of Gabapentinoid Misuse: : An Analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database. (2016)
Stefania Chiappini
and
Fabrizio Schifano
NPS: Medical Consequences Associated with Their Intake. (2016)
Fabrizio Schifano,
Laura Orsolini,
Duccio Papanti
and
John Corkery
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids : BB-22, 5F-PB-22, 5F-AKB-48 and STS-135. (2016)
Maria Antonietta De Luca,
M. Paola Castelli,
Barbara Loi,
Alessandra Porcu,
Mariella Martorelli,
Cristina Miliano,
Kathryn Kellett,
Colin Davidson,
Jacqueline L. Stair,
Fabrizio Schifano
and
Gaetano Di Chiara
The Psychonauts: mind’s navigators or chemical experimenters? (2016)
Laura Orsolini,
Roberta Vecchiotti,
Duccio Papanti,
Alessandro Valchera,
John Corkery
and
Fabrizio Schifano
The novel psychoactive substances: clinical and pharmacological issues. (2016)
Fabrizio Schifano,
Laura Orsolini,
Duccio Papanti
and
John Corkery
The characteristics of deaths involving kratom in the United Kingdom and elsewhere. (2016)
John Corkery,
Hugh Claridge,
Christine Goodair,
Duccio Papanti,
Laura Orsolini,
Sophie Koerber
and
Fabrizio Schifano
The consequences of drug misuse on post-marketing surveillance. (2016)
Fabrizio Schifano,
Duccio Papanti,
Laura Orsolini
and
John Corkery
Novel psychoactive substances. (2016)
Laura Orsolini,
Duccio Papanti,
Roberta Vecchiotti,
Alessandro Valchera,
John Corkery
and
Fabrizio Schifano
The potential utility of some legal highs in CNS disorders. (2016)
Colin Davidson
and
Fabrizio Schifano
2015
Deaths of individuals aged 16-24 years in the UK after using mephedrone. (2015)
Barbara Loi,
John Corkery,
Hugh Claridge,
Christine Goodair,
Stephania Chiappini,
Carla Gimeno Clemente
and
Fabrizio Schifano
Methoxetamine-related deaths in the UK : an overview. (2015)
Stephania Chiappini,
Hugh Claridge,
John Corkery,
Christine Goodair,
Barbara Loi
and
Fabrizio Schifano
Profiling online recreational/prescription drugs' customers and overview of drug vending virtual marketplaces. (2015)
Laura Orsolini,
Giulia Francesconi,
Duccio Papanti,
Arianna Giorgetti
and
Fabrizio Schifano
Venlafaxine as the ‘baby ecstasy’? : Literature overview and analysis of web-based misusers’ experiences. (2015)
Giulia Francesconi,
Laura Orsolini,
John Corkery,
Duccio Papanti
and
Fabrizio Schifano
Olanzapine as the ideal ‘trip terminator’? : Analysis of online reports relating to antipsychotics’s use and misuse following occurance of novel psychoactive substance-related psychotic symptoms. (2015)
Giuseppe Valeriani,
Ornella Corazza,
Francesco Saverio Bersani,
Claudia Melcore,
Antonio Metastasio,
Giuseppe Bersani
and
Fabrizio Schifano
Survey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacists. (2015)
Amira Guirguis,
John Corkery,
Jacqueline Stair,
Stewart Kirton,
Mire Zloh,
Christine Goodair,
Fabrizio Schifano
and
Colin Davidson
Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4 butanediol (1,4-BD; BDO) : a literature review with a focus on UK fatalities related to non-medical use. (2015)
John Corkery,
Barbara Loi,
Hugh Claridge,
Christine Goodair,
Ornella Corazza,
Simon Elliott
and
Fabrizio Schifano
Mind Navigators of Chemicals' Experimenters? A Web-Based Description of E-Psychonauts. (2015)
Laura Orsolini,
Gabriele Duccio Papanti,
Giulia Francesconi
and
Fabrizio Schifano
Novel psychoactive substances of interest for psychiatry. (2015)
Fabrizio Schifano,
Laura Orsolini,
Duccio Papanti
and
John Corkery
The “Eyeballing” technique : an emerging and alerting trend of alcohol misuse. (2015)
Saverio Bersani,
Ornella Corazza,
G. Albano,
S. Bruschi,
A. Minichino,
R. Vicinanza,
Giuseppe Bersani,
Giovanni Martinotti
and
Fabrizio Schifano
2014
The diffusion of Performance and Image Enhancing Drugs (PIEDs) on the internet : The abuse of the cognitive enhancer Piracetam. (2014)
Ornella Corazza,
Saverio Bersani,
Roberto Brunoro,
G. Valeriani,
Giovanni Martinotti
and
Fabrizio Schifano
A systematic review of counterfeit and substandard medicines in field quality surveys. (2014)
Abdulaziz Alghannam,
Zoe Aslanpour,
Sara Evans
and
Fabrizio Schifano
Substance use in the club scene of Rome : a pilot study. (2014)
Alessandro Vento,
Giovanni Martinotti,
Eduardo Cinosi,
Matteo Lupi,
Tiziano Acciavatti,
Dario Carrus,
Rita Santacroce,
Eleonora Chillemi,
Ludovica Bonifaci,
Massimo di Giannantonio,
Ornella Corazza
and
Fabrizio Schifano
25C-NBOMe: preliminary data on pharmacology, psychoactive effects and toxicity of a new potent hallucinogenic drug. (2014)
Francesco Saverio Bersani,
Ornella Corazza,
Gabriella Albano,
Giuseppe Valeriani,
Rita Santacroce,
Flamina Bolzan,
Eduardo Cinosi,
Pierluigi Simonato,
Giovanni Martinotti,
Giuseppe Bersani
and
Fabrizio Schifano
Monitoring novel psychoactive substances allegedly offered online for sale in Persian and Arabic languages. (2014)
Ornella Corazza,
Sulaf Assi,
S. Malekianragheb,
M Beni,
Iman Bigdeli,
Zoe Aslanpour
and
Fabrizio Schifano
Sexual enhancement products for sale online : raising awareness of the psychoactive effects of Yohimbine, Maca, Horny Goat Weed and Ginkgo Biloba. (2014)
Ornella Corazza,
Giovanni Martinotti,
Rita Santacroce,
E. Chilemi,
Fabrizio Schifano
and
S. Cellek
Legal highs: safe and legal heavens? : A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK. ["Legal highs": paradisi sicuri e legali? Uno studio sulla diffusione, conoscenza e consapevolezza del rischio delle nuove droghe psicoattive tra gli studenti del Regno Unito]. (2014)
Ornella Corazza,
Pierluigi Simonato,
John Corkery,
Giuseppina Trincas
and
Fabrizio Schifano
‘Special M’ related fatalities in the UK. (2014)
Stephania Chiappini,
Hugh Claridge,
John Corkery,
Christine Goodair,
Barbara Loi
and
Fabrizio Schifano
The evolution and characteristics of UK deaths involving GHB and its analogues. (2014)
John Corkery,
Barbara Loi,
Hugh Claridge,
Christine Goodair,
Ornella Corazza,
Simon Elliott
and
Fabrizio Schifano
Drug-related deaths in the UK: January-December 2012 : Annual report 2013. (2014)
John Corkery,
Hugh Claridge,
Barbara Loi,
Christine Goodair
and
Fabrizio Schifano
"Spice", "Kryptonite", "Black Mamba": An overview of brand names and marketing stragtegies of Novel Psychoactive Substances on the Web. (2014)
Ornella Corazza,
G. Valeriani,
F. S. Bersani,
John Corkery,
Giovanni Martinotti,
Giuseppe Bersani
and
Fabrizio Schifano
2013
Can reinforcement-based interventions to reduce drug use successfully be adapted to routine opioid maintenance treatment? (2013)
Michael Specka,
Antje Öning,
Jürgen Kluwig,
Fabrizio Schifano,
Markus Banger,
Wolfgang Lange,
Hildegard Lax,
Bärbel Marrziniak,
Claudia Schüngel
and
Norbert Scherbaum
Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse. (2013)
A.E. Vento,
Fabrizio Schifano,
Federica Gentili,
Francesco Pompei,
John Corkery,
Georgios D. Kotzalidis
and
Paolo Girardi
Factors Impacting on the Evolution and Characteristics of UK Deaths Involving‘Traditional’ and ‘New’ Stimulants. (2013)
John Corkery
and
Fabrizio Schifano
Fatalities Associated with Mephedrone in Combination with Other Stimulant Drugs in Young People Aged 16-24 Years. (2013)
Barbara Loi,
Stephania Chiappini,
Hugh Claridge,
John Corkery,
Carla Gimeno Clemente,
Christine Goodair
and
Fabrizio Schifano
Methoxetamine: An Analogue of Ketamine. (2013)
Stephania Chiappini,
Hugh Claridge,
John Corkery,
Carla Gimeno Clemente,
Christine Goodair,
Barbara Loi
and
Fabrizio Schifano
The Unregulated Psychoactive Compound: ‘Benzo Fury’. (2013)
Carla Gimeno Clemente,
Stephania Chiappini,
Hugh Claridge,
John Corkery,
Christine Goodair,
Barbara Loi
and
Fabrizio Schifano
UK deaths associated with ‘Z’ drugs (Zopiclone, Zolpidem & Zaleplon). (2013)
Salvatore Casula,
Hugh Claridge,
John Corkery,
Carla Gimeno Clemente,
Christine Goodair,
Barbara Loi
and
Fabrizio Schifano
Drops of Madness? : Recreational misuse of Tropicamide collyrium: early warning alerts from Russia and Italy. (2013)
Saverio Bersani,
Ornella Corazza,
Pierluigi Simonato,
Raffaele Lovaste,
Linda Levari,
A Mylokosta
and
Fabrizio Schifano
MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; ‘sparkle’; ‘mindy’) toxicity : a brief overview and update. (2013)
John Corkery,
Simon Elliott,
Fabrizio Schifano,
Ornella Corazza
and
Abdol Hamid Ghodse
Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances (NPS) in the EU : the outcomes of the ReDNet project. (2013)
Ornella Corazza,
Sulaf Assi,
Pierluigi Simonato,
John Corkery,
Saverio Bersani,
Zsolt Demetrovics,
Jacqueline Stair,
Suzanne Fergus,
Cinzia Pezzolesi,
Manuela Pasinetti,
Paolo Deluca,
C. Drummond,
Ursula Blaszko,
Jacek Moskalewicz,
Barbara Mervo,
Lucia Di Furia,
Magi Farre,
Liv Flesland,
Agnieszka Pisarska,
Harry Shapiro,
Holger Siemann,
Arvid Skutle,
Elias Sferrazza,
Marta Torrens,
Farran Sambola,
Peer van der Kreeft,
Norbert Scherbaum
and
Fabrizio Schifano
Novel psychoactive substances as a new challenge for health professionals : results of a survey carried out in Italy. (2013)
Pierluigi Simonato,
Ornella Corazza
and
Fabrizio Schifano
From "Special K" to "Special M" : The Evolution of the Recreational use of Ketamine and Methoxetamine. (2013)
Ornella Corazza,
Sulaf Assi
and
Fabrizio Schifano
New psychoactive substancesthe youth and professionals informational needs. (2013)
Agnieszka Pisarska,
Jacek Moskalewicz,
Ornella Corazza,
Sulaf Assi,
Pierluigi Simonato,
John Corkery,
Zsolt Demetrovics,
Jacqueline Stair,
Suzanne Fergus,
Cinzia Pezzolesi,
Manuela Pasinetti,
Paolo Deluca,
Colin Drummond,
Ursula Blaszko,
Barbara Mervo,
Lucia Di Furia,
Magi Farre,
Liv Flesland,
Harry Shapiro,
Holger Siemann,
Arvid Skutle,
Marta Torrens,
Farran Sambola,
Peer van der Kreeft,
Norbert Scherbaum
and
Fabrizio Schifano
Novel Psychoactive Substances (NPS) : a Study on Persian Language Websites. (2013)
Imanollah Bidgeli,
Ornella Corazza,
Zoe Aslanpour
and
Fabrizio Schifano
Drug-related deaths in the UK : Annual Report 2012. (2013)
A. Hamid Ghodse,
John Corkery,
Hugh Claridge,
Christine Goodair
and
Fabrizio Schifano
Analysis of online reports on the potential misuse of benzidamine. (2013)
Fabrizio Schifano,
Ornella Corazza,
Alessandro Marchi,
Giuditta di Melchiorre,
Elias Sferrazza,
Aurora Enea,
Z. Davey,
Ursula Blaszko
and
Paolo Deluca
Editorial: Second International Conference on Novel Psychoactive Substances (NPSs) : Keynote Addresses and Conference Abstracts. (2013)
Andy Parrott,
Ornella Corazza,
Fabrizio Schifano,
Paul Griffiths,
Roumen Sedevof,
Ana Gallegos,
Robin Murray,
Zsolt Demetrovics,
Val Curran,
Giuseppe Bersani
and
L. Singer
2012
Pregabalin misuse-related issues; Intake of large dosages, drug-smoking allegations, and possible association with myositis : Two case reports. (2012)
D. Carrus
and
Fabrizio Schifano
The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine) : A brief review. (2012)
John Corkery,
E. Durkin,
S. Elliott,
Fabrizio Schifano
and
A. Hamid Ghodse
Trends in UK deaths associated with abuse of volatile substances, 1971-2009. (2012)
A. Hamid Ghodse,
John Corkery,
Kapil Ahmed
and
Fabrizio Schifano
Drug-related deaths in the UK: Annual Report 2011 [January-December 2010] : Drug-related deaths reported by Coroners in England, Wales, Northern Ireland, Guernsey, Jersey and the Isle of Man; Police forces in Scotland; & the Northern Ireland Statistics and Research Agency. (2012)
A. Hamid Ghodse,
John Corkery,
Fabrizio Schifano,
Antonio Piolanti,
Giuseppina Trincas
and
Giuditta Di Melchiorre
Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, meow meow) in the United Kingdom. (2012)
Fabrizio Schifano,
John Corkery
and
A.Hamid Ghodse
Impact of community pharmacy diabetes monitoring and education programme on diabetes management : a randomised controlled study. (2012)
Majid Ali,
Fabrizio Schifano,
Paul Robinson,
G. Phillips,
L. Doherty,
P. Melnick,
L. Laming,
A. Sinclair
and
S. Dhillon
E-Psychonauts : Conducting research in online drug forum communities. (2012)
Zoe Davey,
Paolo Deluca,
Fabrizio Schifano
and
Ornella Corazza
Does clinical handover promote situation awareness? : Implications for person-centered healthcare. (2012)
Cinzia Pezzolesi,
Tanya Manser,
Fabrizio Schifano,
Andrzej Kostrzewski,
John Pickles,
Harriet Nicholls,
Daniel Fishman,
Arshad Mubarik
and
S. Dhillon
Mephedrone-related fatalities in the United Kingdom : contextual, clinical and practical issues. (2012)
John Corkery,
Fabrizio Schifano
and
Abdol H Ghodse
Phenazepam abuse in the UK : an emerging problem causing serious adverse health problems, including death. (2012)
John Martin Corkery,
Fabrizio Schifano
and
Abdol Hamid Ghodse
5,6-Methylenedioxy-2-aminoindane : from laboratory curiosity to 'legal high'. (2012)
C. T. Gallagher,
S. Assi,
J. L. Stair,
S. Fergus,
Ornella Corazza,
John Corkery
and
Fabrizio Schifano
2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) : A preliminary review. (2012)
John Corkery,
Fabrizio Schifano,
A. Hamid Ghodse,
S. Elliott
and
Ornella Corazza
Identifying emerging trends in recreational drug use : outcomes from the Psychonaut Web Mapping Project. (2012)
Paolo Deluca,
Zoe Davey,
Ornella Corazza,
Manuela Pasinetti,
C. Pezzolesi,
Fabrizio Schifano,
Lucia Di Furia,
Magi Farre,
Marta Torrens,
Liv Flesland,
Arvid Skutle,
E. Iversen,
Miia Mannonen,
A. Majava,
Teuvo Peltoniemi,
Norbert Scherbaum,
Holger Siemann
and
Peer van der Kreeft
'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate. (2012)
Ornella Corazza,
Fabrizio Schifano,
Zsolt Demetrovics
and
W. van den Brink
Phenomenon of new drugs on the Internet : the case of ketamine derivative methoxetamine. (2012)
Ornella Corazza,
Fabrizio Schifano,
Pierluigi Simonato,
Suzanne Fergus,
Sulaf Assi,
Jacqueline Stair,
John Corkery,
Giuseppina Trincas,
Paolo Deluca,
Zoe Davey,
Ursula Blaszko,
Zsolt Demetrovics,
Jacek Moskalewicz,
Aurora Enea,
Giuditta di Melchiorre,
Barbara Mervo,
Lucia Di Furia,
Magi Farre,
Liv Flesland,
Manuela Pasinetti,
Cinzia Pezzolesi,
Agnieszka Pisarska,
Harry Shapiro,
Holger Siemann,
Arvid Skutle,
Aurora Enea,
Giuditta di Melchiorre,
Elias Sferrazza,
Marta Torrens,
Peer van der Kreeft,
Daniela Zummo
and
Norbert Scherbaum
2011
Development and evaluation of a Handover Performance Tool (HPT) for medical shift handovers. (2011)
Cinzia Pezzolesi,
S. Dhillon,
Fabrizio Schifano,
Andrzej Kostrzewski,
John Pickles
and
Tanya Manser
Consideration of the novel psychoactive substances (‘legal highs’). (2011)
John Corkery,
Fabrizio Schifano
and
Ornella Corazza
Longitudinal patterns of benzodiazepine consumption in a German cohort of methadone maintenance treatment patients. (2011)
Michael Specka,
Udo Bonnet,
Martin Heilmann,
Fabrizio Schifano
and
Norbert Scherbaum
Mephedrone, new kid for the chop? (2011)
Adam R. Winstock,
Luke R. Mitcheson,
Paolo Deluca,
Zoe Davey,
Ornella Corazza
and
Fabrizio Schifano
'Bundle of fun' or 'bunch of problems'? : Case series of khat-related deaths in the UK. (2011)
John Corkery,
Fabrizio Schifano,
Adenekan Oyefeso,
A. Hamid Ghodse,
Thomy Tonia,
Vinesha Naidoo
and
Jennifer Button
Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997 - 2007. (2011)
G. Zamparutti,
Fabrizio Schifano,
John Corkery,
A. Oyefeso
and
A. Hamid Ghodse
Designer drugs on the Internet : a phenomenon out-of-control? : The emergence of hallucinogenic drug Bromo-Dragonfly. (2011)
Ornella Corazza,
Fabrizio Schifano,
Magi Farre,
Paolo Deluca,
Zoe Davey,
Colin Drummond,
Marta Torrens,
Zsolt Demetrovics,
Lucia Di Furia,
Liv Flesland,
Barbara Mervo,
Jacek Moskalewicz,
Agnieszka Pisarska,
Harry Shapiro,
Holger Siemann,
Arvid Skutle,
Cinzia Pezzolesi,
Peer van der Kreeft
and
Norbert Scherbaum
Emergence and identification of new products of designer drug products from the internet. (2011)
Sulaf Assi,
Suzanne Fergus,
Jacqueline Stair,
Ornella Corazza
and
Fabrizio Schifano
Impact of community pharmacy diabetes monitoring and education programme on diabetes management : a randomised controlled study. (2011)
Majid Ali,
Fabrizio Schifano,
Paul Robinson,
G. Phillips,
L. Doherty,
P. Melnick,
L. Laming,
A. Sinclair
and
S. Dhillon
Is there a recreational misuse potential for Pregabalin? : Analysis of anecdotal online reports in comparison with related Gabapentin and Clonazepam data. (2011)
Fabrizio Schifano,
S. D'Offizi,
M. Piccione,
Ornella Corazza,
P. Deluca,
Z. Davey,
G. di Melchiorre,
L. DiFuria,
M. Farre,
L. Flesland,
M. Mannonen,
A. Majava,
S. Pagani,
T. Peltoniemi,
H. Siemann,
A. Skutle,
M. Torrens,
C. Pezzolesi,
P. van der Kreeft
and
N. Scherbaum
Mephedrone (4-methylmethcathinone; 'meow meow') : chemical, pharmacological and clinical issues. (2011)
Fabrizio Schifano,
Antonio Albanese,
Suzanne Fergus,
Jacqueline Stair,
Paolo Deluca,
Ornella Corazza,
Zoe Davey,
John Corkery,
Holger Siemann,
Norbert Scherbaum,
Magi' Farre',
Marta Torrens,
Zsolt Demetrovics,
A. Hamid Ghodse
and
ReDNet Res Grp, Psychonaut Web Mapping
Overview of literature and information on "khat-related" mortality: a call for recognition of the issue and further research. (2011)
John Corkery,
Fabrizio Schifano,
Adenekan Oyefeso,
A. Hamid Ghodse,
Thomy Tonia,
Vinesha Naidoo
and
Jennifer Button
Suicide verdicts as opposed to accidental deaths in substance-related fatalities (UK, 2001–2007). (2011)
A.E. Vento,
M. Pompili,
Fabrizio Schifano,
John Corkery,
M. Innamorati,
P. Girardi
and
H. Ghodse
An introduction to the new phenomenon of Internet-based drugs. (2011)
Harry Shapiro,
Ornella Corazza,
Pierluigi Simonato
and
Fabrizio Schifano
2010
Nuove sostanze d'abuso sul Web : Il ruolo dello Psychonaut Web Mapping Project. (2010)
Fabrizio Schifano,
Ornella Corazza,
A. Ricciardi,
C. Rafanelli,
P. Deluca,
Z. Davey,
L. Di Furia,
M. Farrè,
L. Flesland,
M. Mannonen,
T. Peltoniemi,
C. Pezzolesi,
S. Pagani,
N. Scherbaum,
H. Siemann,
A. Skutle,
M. Torrens
and
P. Van Der Kreeft
Az elektronikus prevenció lehetőségei az új (szintetikus) drogok használatának megelőzésében : a Rekreációs Drogok Európai Hálózatának (Recreational Drugs European Network) bemutatása. (2010)
Zsolt Demetrovics,
Barbara Mervo,
Ornella Corazza,
Zoe Davey,
Paolo Deluca,
C. Drummond,
Aurora Enea,
Jacek Moskalewicz,
G. Di Melchiorre,
Lucia Di Furia,
Liv Flesland,
Luciano Floridi,
F. Iszaj,
Norbert Scherbaum,
Holger Siemann,
Arvid Skutle,
Marta Torrens,
Manuela Pasinetti,
Cinzia Pezzolesi,
Agnieszka Pisarska,
Harry Shapiro,
Elias Sferrazza,
Peer van der Kreeft
and
Fabrizio Schifano
Burnout, coping and job satisfaction in service staff treating opioid addicts : from Athens to Zurich. (2010)
R. Volker,
B. Bernhard,
A. Kokkevi,
Fabrizio Schifano,
R. Room,
J. Palm,
R. Stohler,
L. DiFuria,
J. Rehm,
F. Holscher
and
C. Schwarzer
Clinical handover incident reporting in one UK general hospital. (2010)
Cinzia Pezzolesi,
Fabrizio Schifano,
John Pickles,
William Randell,
Zakar Hussain,
Helen Muir
and
S. Dhillon
“Legal highs” on the net—evaluation of UK-based websites, products and product information. (2010)
M.M. Schmidt,
A. Sharma,
Fabrizio Schifano
and
C. Feinmann
Mass-information : Mephedrone, myths, and the new generation of legal highs. (2010)
Zoe Davey,
Ornella Corazza,
Fabrizio Schifano
and
Paolo Deluca
Near-death states reported in a sample of 50 misusers. (2010)
Ornella Corazza
and
Fabrizio Schifano
Overview of amphetamine-type stimulant mortality data – UK, 1997–2007. (2010)
Fabrizio Schifano,
John Corkery,
Vinesha Naidoo,
Adenekan Oyefeso
and
Hamid Ghodse
Psychoactive drug or mystical incense? : Overview of the online available information on Spice products. (2010)
Fabrizio Schifano,
Ornella Corazza,
Paolo Deluca,
Zoe Davey,
Di Furia Lucia,
Magi Farre,
Liv Flesland,
Miia Mannonen,
Stefania Pagani,
Teuvo Peltoniemi,
Cinzia Pezzolesi,
Norbert Scherbaum,
Holger Siemann,
Arvid Skutle,
Marta Torrens
and
Peer van der Kreeft
Two UK suicides using nicotine extracted from tobacco employing instructions available on the Internet. (2010)
John Corkery,
J. Button,
A.E. Vento
and
Fabrizio Schifano
2006
Deaths and other key indicators regarding cocaine consumption in the UK (1990-2004). (2006)
Fabrizio Schifano
and
John Corkery
Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003). (2006)
Fabrizio Schifano,
John Corkery,
A. Oyefeso
and
A. Hamid Ghodse
Fatal injuries while under the influence of psychoactive drugs: a cross-sectional exploratory study in England. (2006)
A. Oyefeso,
Fabrizio Schifano,
H. Ghodse,
K. Cobain,
R. Dryden
and
John Corkery
Review of Deaths Related to Analgesic- and Cough Suppressant-opioids; England and Wales 1996-2002. (2006)
Fabrizio Schifano,
G. Zamparutti,
F. Zambello,
A. Oyefeso,
P. Deluca,
M. Balestrieri,
D. Little
and
A. Hamid Ghodse
2005
Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002. (2005)
Fabrizio Schifano,
John Corkery,
Eilish Gilvarry,
Paolo Deluca,
Adenekan Oyefeso
and
A. Hamid Ghodse
New trends in the cyber and street market of recreational drugs? : The case of 2C-T-7 ('Blue Mystic'). (2005)
Fabrizio Schifano,
Paolo Deluca,
Lisa Agosti,
Giovanni Martinotti,
John Corkery,
Baldacchino Alex,
Bonan Caterina,
Bothas Heikki,
Brigada Raffaella,
Comacchio Anna,
Di Furia Lucia,
Duarte Rui Eastwood Dorte,
Farré Magi,
Ferreira Susana,
Flores Irene,
Guionnet Claude,
Harder Lisbet,
Stokholm Jensen Lene,
Leoni Mauro,
Littlejohn Christopher,
Majava Aino,
Peltoniemi Teuvo,
Pizza Milena,
Rawaf Salman,
Robert Damien,
Rossi Maria Angela,
Rovetto Francesco,
Scherbaum Norbert,
Siemann Holger,
Tarrago Josep,
Torrens Marta,
Zambello Francesco
and
Psychonaut 2002 Research Group
2003
Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002. (2003)
Fabrizio Schifano,
A. Oyefeso,
John Corkery,
K. Cobain,
R. Jambert-Gray,
G. Martinotti
and
A. Hamid Ghodse
Review of deaths related to taking ecstasy, England and Wales, 1997-2000. (2003)
Fabrizio Schifano,
A. Oyefeso,
L. Webb,
M. Pollard,
John Corkery
and
A. Hamid Ghodse